Panel Discussion: Extrapolating Neurological Indications with the Greatest Potential to Leverage Intranasal Administration
Time: 9:00 am
day: Conference Day Two
Details:
- Empowering opioid overdose, bipolar disorder, anxiety, depression and more with the potential advantages of nasal formulations, such as increased specificity and enhanced potency
- Brainstorming innovative approaches for quantifying subjective metrics like migraine pain relief, anosmia reduction, taste enhancement, and mood improvement for robust quality control
- Delving into anticipated advancements, concerning challenges and expected priorities across the ever-expanding nasal delivery landscape
